EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C15H12NO3.C4H12NO3 |
| Net Charge | 0 |
| Average Mass | 376.409 |
| Monoisotopic Mass | 376.16344 |
| SMILES | O=C(c1ccccc1)c1ccc2n1CCC2C(=O)[O-].[NH3+]C(CO)(CO)CO |
| InChI | InChI=1S/C15H13NO3.C4H11NO3/c17-14(10-4-2-1-3-5-10)13-7-6-12-11(15(18)19)8-9-16(12)13;5-4(1-6,2-7)3-8/h1-7,11H,8-9H2,(H,18,19);6-8H,1-3,5H2 |
| InChIKey | BWHLPLXXIDYSNW-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Roles: | cyclooxygenase 2 inhibitor A cyclooxygenase inhibitor that interferes with the action of cyclooxygenase 2. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. cyclooxygenase 1 inhibitor A cyclooxygenase inhibitor that interferes with the action of cyclooxygenase 1. |
| Applications: | cardiovascular drug A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume. ophthalmology drug Any compound used for the treatment of eye conditions or eye diseases. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. anti-inflammatory agent Any compound that has anti-inflammatory effects. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| ketorolac tromethamine (CHEBI:6130) has part Htris (CHEBI:46097) |
| ketorolac tromethamine (CHEBI:6130) has part ketorolac(1−) (CHEBI:76229) |
| ketorolac tromethamine (CHEBI:6130) has role analgesic (CHEBI:35480) |
| ketorolac tromethamine (CHEBI:6130) has role anti-inflammatory agent (CHEBI:67079) |
| ketorolac tromethamine (CHEBI:6130) has role antineoplastic agent (CHEBI:35610) |
| ketorolac tromethamine (CHEBI:6130) has role cardiovascular drug (CHEBI:35554) |
| ketorolac tromethamine (CHEBI:6130) has role cyclooxygenase 1 inhibitor (CHEBI:50630) |
| ketorolac tromethamine (CHEBI:6130) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| ketorolac tromethamine (CHEBI:6130) has role ophthalmology drug (CHEBI:66981) |
| ketorolac tromethamine (CHEBI:6130) is a organoammonium salt (CHEBI:46850) |
| IUPAC Name |
|---|
| 1,3-dihydroxy-2-(hydroxymethyl)propan-2-aminium 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate |
| Synonyms | Source |
|---|---|
| Ketorolac (+/-)-form tromethamine salt | ChEMBL |
| NSC-758637 | ChEMBL |
| Tarasyn | ChEMBL |
| Brand Names | Source |
|---|---|
| Acular | KEGG DRUG |
| Acular ls | ChEMBL |
| Acular preservative free | ChEMBL |
| Acuvail | ChEBI |
| Dolac | ChEBI |
| Ketorolac tromethamine component of omidria | ChEMBL |
| Manual Xrefs | Databases |
|---|---|
| D00813 | KEGG DRUG |
| DB00465 | DrugBank |
| HMDB0014608 | HMDB |
| Registry Numbers | Sources |
|---|---|
| Reaxys:6463165 | Reaxys |
| CAS:74103-07-4 | KEGG DRUG |
| CAS:74103-07-4 | ChemIDplus |
| Citations |
|---|